Body Fat and Triglyceride Link and Your Genetics

By the ExomeDNA Research Team | Last reviewed May 25, 2026

Body fat and triglycerides are metabolically linked — elevated fat storage and higher blood triglyceride levels often move together, shaped partly by shared genetic architecture. Research has identified common variants near genes like KLF14, GRB14, and TOMM40 that associate with this combined signal, influencing how the body partitions energy between storage and circulation. This page explains the science, the key genes, and what the findings mean in everyday terms.

{{MEDICAL_DISCLAIMER}}

What is body fat and triglyceride link?

The relationship between body fat and blood triglycerides is one of the most studied topics in metabolic health. Triglycerides are fats that circulate in the bloodstream, derived from dietary fat and from fat stores that the liver releases into circulation. Body fat — particularly visceral fat accumulated around internal organs — is a major source of circulating free fatty acids that the liver converts into triglycerides.

When the balance between fat storage and fat mobilization shifts, blood triglyceride levels often reflect the change. People who carry more body fat, especially centrally distributed fat, tend to show higher fasting triglyceride levels in population studies — though the relationship is modulated by diet, activity level, and, as research increasingly shows, genetics.

This trait examines the genetic signal associated with the combined body fat and triglyceride profile — asking which common variants are associated with the tendency for these two measures to co-vary. Understanding where that signal comes from can clarify whether a person's genetic architecture favors efficient fat storage, slower fat mobilization, or differences in how the liver packages circulating fats.

The genetics behind body fat and triglyceride link

Genetic studies have identified multiple loci associated with the body fat and triglyceride combination, implicating several biological mechanisms.

Fat tissue transcription and adipogenesis. KLF14, encoding Krüppel-like factor 14, is a transcriptional regulator that influences how fat cells differentiate and manage lipid storage and release. Variants near KLF14 appear in genome-wide studies of both body fat distribution and lipid traits, placing this gene at the intersection of the two signals examined here. Its regulatory effects appear to extend from adipose tissue into systemic lipid metabolism, making it one of the more functionally characterized loci in this space.

Insulin signaling and fat uptake. GRB14 (growth factor receptor-bound protein 14) modulates insulin receptor signaling in peripheral tissues. Variants near GRB14 have been associated with insulin sensitivity phenotypes and lipid traits in population studies. When insulin signaling is altered at the tissue level, both fat storage efficiency and triglyceride handling can be affected — a mechanism consistent with the gene's appearance in combined fat-and-lipid association analyses.

Mitochondrial function and lipid metabolism. TOMM40, located on chromosome 19q near the APOE locus, encodes a component of the outer mitochondrial membrane translocase — the machinery that imports proteins into mitochondria. Mitochondrial function is tightly linked to fatty acid oxidation, and variants near TOMM40 have been found in association studies for multiple lipid-related traits. Because TOMM40 and APOE are in close proximity, regional haplotype effects may also contribute to signals observed in this genomic region.

Other associated loci. Additional genes in the association landscape for this trait include MAFF (a bZIP transcription factor active in liver and other metabolic tissues), SLC22A3 (an organic cation transporter expressed in the liver), and PPP1R3B (a regulator of glycogen synthesis found in multiple lipid GWAS). EYA2 and FAM13A also appear in the top-ranked list, with mechanistic roles in fat-and-lipid biology that remain less characterized than the primary loci.

What the research says

Research base: Moderate. The genetic signal for the body fat and triglyceride combined trait is supported by published genome-wide association research, with multiple replicated loci across studies. The combined phenotype is less studied than either trait individually, and some signals may reflect the genetic architecture of either body fat or triglycerides rather than their interaction specifically. Findings should be interpreted with this context in mind.

Published genome-wide research has identified common variants near genes like KLF14 and GRB14 that associate with combined fat storage and blood lipid signals, implicating shared transcriptional and signaling pathways in the co-regulation of these metabolic traits (Researchers et al., 2021 ^[1]).

The TOMM40 and GRB14 loci — both associated with lipid and insulin signaling phenotypes in prior work — have also emerged in studies of combined body fat and triglyceride endpoints, suggesting that mitochondrial function and insulin receptor modulation may be shared drivers of this metabolic pairing (Researchers et al., 2021 ^[1]).

For a detailed discussion of how genetic evidence is evaluated, visit our /methodology page.

How body fat and triglyceride link affects you

The co-occurrence of higher body fat and elevated triglycerides is a pattern that appears throughout research on metabolic health. From a genetic standpoint, some of the associated variants suggest that the liver's fat-packaging functions and adipose tissue's storage-versus-release balance are being tuned by shared regulatory signals.

Genetics is not the only — or even the primary — driver of this pattern. Diet composition, physical activity level, alcohol consumption, and hormonal factors all influence both body fat distribution and triglyceride levels. The genetic contribution represents a background tendency that interacts with these modifiable factors.

For ExomeDNA users, the body fat and triglyceride link trait provides a window into the metabolic pathways that matter for cardiometabolic health. People with a genetic tendency toward higher combined fat-and-triglyceride scores may find that dietary and lifestyle modifications produce particularly meaningful responses, since those levers address the same biological pathways the associated genes modulate.

Working with your result

Practical strategies relevant to this trait's underlying biology:

• Reduce refined carbohydrate and added sugar intake: Dietary carbohydrates — particularly simple sugars and refined starches — are a primary driver of triglyceride synthesis in the liver, making this one of the most direct dietary levers for blood lipid levels.
• Increase aerobic activity: Regular moderate-intensity exercise has been shown in multiple studies to lower fasting triglycerides and reduce visceral fat, addressing both components of this trait simultaneously.
• Limit alcohol: Alcohol is a significant driver of hepatic triglyceride production; even moderate intake can measurably raise fasting triglycerides in susceptible individuals.
• Support mitochondrial function: The TOMM40 signal points toward mitochondrial protein import as a relevant pathway. Evidence suggests that aerobic fitness and adequate B-vitamin status for mitochondrial metabolism support this pathway.
• Monitor fasting lipid panels: Because triglycerides vary substantially with recent meals, fasting measurements are most informative for tracking trends over time.

These steps are grounded in published nutritional and exercise science and are appropriate for broad populations, not specific to any single genetic profile.

Related traits and genes

The body fat and triglyceride link trait connects to a wider set of metabolic traits in ExomeDNA's database:

• HDL Cholesterol Genetics — the protective lipoprotein inversely associated with triglycerides in many individuals
• LDL Cholesterol Genetics — the atherogenic lipoprotein sharing genetic architecture with the lipid network
• Visceral Fat Genetics — the specific fat depot most strongly linked to metabolic outcomes

Related cross-category traits:

• Type 2 Diabetes Risk — shares insulin signaling genetics via the GRB14 pathway
• Cardiovascular Risk Genetics — lipid genetics are a primary input to cardiovascular risk models

Key genes on this page: KLF14, GRB14, TOMM40, MAFF, SLC22A3, PPP1R3B, EYA2, FAM13A, CCDC92.

Frequently asked questions

What does 'body fat and triglyceride link' actually measure? It reflects the genetic association with a combined metabolic signal — variants that appear in research connecting elevated body fat, particularly central adiposity, with elevated blood triglyceride levels. It is not a single biomarker but a genetic portrait of the fat storage and fat circulation pathways that tend to co-vary.

Are triglycerides the same as body fat? They are related but distinct. Triglycerides are the dominant fat molecule circulating in blood and stored in fat tissue. Blood triglycerides (measured in a fasting lipid panel) reflect recent dietary intake and the liver's fat-packaging activity. Body fat percentage reflects total fat storage. They often correlate, but not perfectly — someone can carry more body fat with normal fasting triglycerides, or show elevated triglycerides with relatively lean body composition.

Does the APOE gene affect this trait? APOE, located near TOMM40 on chromosome 19q, is one of the most studied lipid metabolism genes. Because TOMM40 and APOE are in close proximity, haplotype effects from the APOE region may contribute to associations observed near TOMM40 in studies of fat and lipid traits. Research on the specific contribution of APOE alleles to combined body fat and triglyceride signals is ongoing; the relationship is complex and ancestry-dependent.

Can I lower my triglycerides even with higher-risk variants? Yes. The genetic signal represents a population-level statistical tendency, not a fixed outcome. Research consistently shows that reducing refined carbohydrate intake, increasing physical activity, and limiting alcohol are effective strategies for lowering triglycerides across a wide range of genetic backgrounds. The specific response magnitude may vary by individual, but the direction of effect is generally consistent.

Why does KLF14 appear in both body fat and triglyceride studies? KLF14 is a transcription factor that regulates gene expression in adipose tissue, with downstream effects on how fat cells store lipids and how the liver manages lipid metabolism. Because it sits at a regulatory hub influencing both adipogenesis and fat mobilization, its genetic variation shows up in genome-wide studies of multiple fat-and-lipid-related traits.

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-25.

{{FDAWELLNESSFOOTER}}

References

1. Researchers et al. (2021). Genome-wide association study of body fat and triglyceride levels. PMID: 33619380.

Data sources: GWAS Catalog, Open Targets, ClinVar, ClinGen (accessed 2026-05-25).